Form 13-F position report

* ICU MED INC

Reported by SEGALL BRYANT & HAMILL LLC

ICUI CUSIP 44930G107 Manager CIK 0001006378

Reported 484,635 shares, up 155 (0.0%) from the prior quarter.

Reported value 7.6%; share count 0.0% vs. the prior quarter.

Added
% of reported 13F value 0.97% This manager · Q1 2024
Shares 484,635 Quarter-end amount reported
Reported value $52,011,028 Fair value at quarter end
Consecutive quarters held 27 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 42053000
2021-12-31 44568000
2022-03-31 58247000
2022-06-30 61195000
2022-09-30 57180000
2022-12-31 59329000
2023-03-31 61199000
2023-06-30 66418541
2023-09-30 55085683
2023-12-31 48322035
2024-03-31 52011028
2024-06-30 53463863
2024-09-30 60760166
2024-12-31 47608794
2025-03-31 41335151
2025-06-30 39073451
2025-09-30 33651299
2025-12-31 37806837
2026-03-31 28950651
2026-06-30 32552823

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * ICU MED INC held by SEGALL BRYANT & HAMILL LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 222,052 -2,111 (-0.9%) 0.39% $32,552,823 2026-08-12
Q1 2026 Reduced 224,163 -40,832 (-15.4%) 0.36% $28,950,651 2026-05-15
Q4 2025 Reduced 264,995 -15,526 (-5.5%) 0.51% $37,806,837 2026-02-13
Q3 2025 Reduced 280,521 -15,154 (-5.1%) 0.45% $33,651,299 2025-11-12
Q2 2025 Reduced 295,675 -2,000 (-0.7%) 0.55% $39,073,451 2025-08-12
Q1 2025 Reduced 297,675 -9,142 (-3.0%) 0.63% $41,335,151 2025-05-02
Q4 2024 Reduced 306,817 -26,627 (-8.0%) 0.66% $47,608,794 2025-02-11
Q3 2024 Reduced 333,444 -116,778 (-25.9%) 0.83% $60,760,166 2024-11-08
Q2 2024 Reduced 450,222 -34,413 (-7.1%) 0.95% $53,463,863 2024-08-14
Q1 2024 Added 484,635 +155 (0.0%) 0.97% $52,011,028 2024-05-15
Q4 2023 Added 484,480 +21,614 (4.7%) 0.93% $48,322,035 2024-02-14
Q3 2023 Added 462,866 +90,126 (24.2%) 0.64% $55,085,683 2023-11-09
Q2 2023 Added 372,740 +1,743 (0.5%) 0.69% $66,418,541 2023-08-14
Q1 2023 Reduced 370,997 -5,744 (-1.5%) 0.66% $61,199,000 2023-05-15
Q4 2022 Reduced 376,741 -2,941 (-0.8%) 0.66% $59,329,000 2023-02-14
Q3 2022 Added 379,682 +7,418 (2.0%) 0.68% $57,180,000 2022-11-14
Q2 2022 Added 372,264 +110,658 (42.3%) 0.69% $61,195,000 2022-08-15
Q1 2022 Added 261,606 +73,814 (39.3%) 0.56% $58,247,000 2022-05-13
Q4 2021 Added 187,792 +7,603 (4.2%) 0.41% $44,568,000 2022-02-14
Q3 2021 Added 180,189 +17,304 (10.6%) 0.4% $42,053,000 2021-11-03
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

278 managers reported * ICU MED INC for Q1 2024.

Managers reporting * ICU MED INC in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 2,594,888 +36,246 < 0.01% $278,483,380 44 qtrs
JANUS HENDERSON GROUP PLC Reduced 2,471,496 -146,437 0.14% $265,241,190 28 qtrs
VANGUARD GROUP INC Added 2,452,720 +11,991 < 0.01% $263,225,911 44 qtrs
FULLER & THALER ASSET MANAGEMENT INC Added 1,534,742 +62,692 0.72% $164,708,506 8 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 1,379,190 -196,266 0.03% $148,014,670 44 qtrs
JPMorgan Chase & Co Added 817,917 +79,025 < 0.01% $87,778,852 44 qtrs
STATE STREET CORPORATION Reduced 709,793 -13,889 < 0.01% $76,174,985 44 qtrs
MORGAN STANLEY Added 650,721 +66,088 < 0.01% $69,835,585 44 qtrs
SCHRODER INVESTMENT MANAGEMENT GROUP Added 612,143 +178,291 0.08% $65,695,187 17 qtrs
Neuberger Berman Group LLC Added 584,169 +164,828 0.05% $62,693,017 30 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
348,644
Shared
0
None
135,991

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.